RAAVEN Trademark
Trademark Overview
On Monday, September 30, 2024, a trademark application was filed for RAAVEN with the United States Patent and Trademark Office. The USPTO has given the RAAVEN trademark a serial number of 79409327. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, November 14, 2024. This trademark is owned by Raaven Therapeutics AB. The RAAVEN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Research in the field of gene therapy; biological research, clinical research and medical research; medical research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific research for medical purposes in the area of cancerous diseases; medical research laboratory services; consultancy relating to research in the field of pharmacogenetics; pharmaceutical research and development; consultancy in the field of pharmaceutical research; platform as a service [PaaS] featuring computer software platforms for use in screening and/or validation within gene therapy research.
General Information
| Serial Number | 79409327 |
| Word Mark | RAAVEN |
| Filing Date | Monday, September 30, 2024 |
| Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
| Status Date | Thursday, November 14, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Research in the field of gene therapy; biological research, clinical research and medical research; medical research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific research for medical purposes in the area of cancerous diseases; medical research laboratory services; consultancy relating to research in the field of pharmacogenetics; pharmaceutical research and development; consultancy in the field of pharmaceutical research; platform as a service [PaaS] featuring computer software platforms for use in screening and/or validation within gene therapy research. |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, November 14, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Raaven Therapeutics AB |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | SE |
Trademark Events
| Event Date | Event Description |
| Thursday, November 14, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, November 15, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, November 15, 2024 | APPLICATION FILING RECEIPT MAILED |
